|
|
|
|
| LEADER |
01496nam a2200229 u 4500 |
| 001 |
EB001840332 |
| 003 |
EBX01000000000000001004321 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 020 |
|
|
|a 9780994438102
|
| 100 |
1 |
|
|a Li, Xiaogang
|e [editor]
|
| 245 |
0 |
0 |
|a Polycystic kidney disease
|h Elektronische Ressource
|c [edited by] Xiaogang Li
|
| 260 |
|
|
|a Brisbane, Australia
|b Codon Publications
|c November, 2015, 2015
|
| 300 |
|
|
|a 1 PDF file (xx, 488 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Polycystic Kidney Diseases
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK373386
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a Polycystic kidney disease (PKD) is characterized by the presence of fluid-filled cysts in the kidneys. It is the fourth most common cause of chronic renal insufficiency or end-stage kidney disease. This book focuses on the basic and clinical aspects of the burgeoning PKD research under three sections. Section 1 provides a comprehensive guide to the diagnosis, management and treatment of PKD. Section 2 covers most of the fundamental molecular and cellular mechanisms underlying PKD, and how this knowledge is contributing to the development of potential novel therapeutic agents. Finally, section 3 focuses on extra-renal or secondary complications of PKD.
|